Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
Caffeine is known to enhance physical and mental performance, but few beverages combine caffeine with electrolytes and carbohydrates to enhance exercise performance. This study evaluates a caffeinated electrolyte-glucose drink's effect on endurance, strength, and cognition. Using a repeated-measures, cross-over design, 20 trained cyclists will complete one familiarization and four randomized 3-hour experimental trials (Liquid I.V.™ Energy Multiplier, Hydration Multiplier, Sugar-Free Hydration Multiplier, and water). Each trial includes 2 hours of cycling in a warm environment (32ºC), followed by strength and cognitive assessments. Cycling performance, capillary blood, urine, and expiratory gases will be collected.
Full description
Each subject will complete 5 trials (1 familiarization and 4 experimental) consisting of approximately 2 hours cycling in a warm environment (90ºF), followed by strength assessment and cognitive assessment via questionnaire. Each trial will be identical, with the only difference being the type of drink consumed during each trial. The first trial will be for familiarization without any blood sampling. The rest of the trials will be completed in a randomized order and the drink consumed
Cycling Endurance Exercise Performance
The exercise test will consist of a series of three consecutive cycling sets in a warm environment (90ºF), with each series consisting of:
At regular intervals throughout the exercise task, body weight, blood samples, respiratory gasses, and perceptual data will be collected. See study schematic provided below for specific measurement timepoints.
Upon completion of the cycling task subjects will moved to another room with cool temperature (70ºF), where strength and cognitive function will be assessed to determine the influence of each beverage on indices of exercise performance and fatigue.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
• History of caffeine sensitivity
Primary purpose
Allocation
Interventional model
Masking
26 participants in 4 patient groups, including a placebo group
Loading...
Central trial contact
Stavros Kavouras, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal